We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





All Virtual 2020 AACC Uses Artificial Intelligence to Connect Exhibitors and Attendees

By LabMedica International staff writers
Posted on 17 Dec 2020
The 2020 AACC Annual Scientific Meeting & Clinical Lab Expo held by the American Association for Clinical Chemistry (Washington, DC, USA) offered five days from December 13-17 packed with opportunities to learn about current and emerging science on a virtual platform.

The 2020 AACC virtual meeting AACC brought the latest interactive technology for all educational sessions plus innovative networking opportunities. More...
Attendees have access to all scientific and plenary sessions, on-demand, through January 18, 2021. With more than 200 scientific sessions, the breadth of clinical laboratory science education was robust and prepared attendees for what’s ahead in the lab. A key focus this year was on the latest SARS-CoV-2 testing topics, including seven late-breaking special sessions. Plenary sessions included discussions on using artificial intelligence and machine learning to improve patient outcomes, new therapies for cancer, creating cross-functional diagnostic management teams, and accelerating health research and medical breakthroughs through the use of precision medicine.

At the virtual AACC Clinical Lab Expo, more than 150 exhibitors filled the digital floor with displays and vital information about the latest diagnostic technology, including but not limited to SARS-CoV-2 testing, mobile health, molecular diagnostics, mass spectrometry, point-of-care, and automation. Attendees also had the opportunity to win prizes while engaging with exhibitors to learn about the latest technologies and solutions for their lab. The event also provided the opportunity to connect with colleagues and world experts at an industry talk or during one of the many planned social events. The virtual meeting platform’s matchmaking technology, powered by artificial intelligence software, recommended exhibitors and other attendees to connect with based on their self-identified professional goals and interests. The attendees then reached out to these individuals through the virtual platform to schedule meetings with them during the Clinical Lab Expo.


Related Links:
American Association for Clinical Chemistry


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
Silver Member
Quality Control Material
Multichem ID-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.